On Friday, Oracle Corporation (NYSE:ORCL)’s shares declined -0.52% to $36.55.
Oracle Corporation (ORCL) declared fiscal 2016 Q1 results. The strengthening of the U.S. dollar contrast to foreign currencies had a significant impact on results in the quarter. Total Revenues were $8.4 billion, down 2% in U.S. dollars but up 7% in constant currency. Cloud plus On-Premise Software Revenues were $6.5 billion, down 2% in U.S. dollars and up 6% in constant currency. Total Cloud Revenues were $611 million, up 29% in U.S. dollars and up 34% in constant currency. Cloud software as a service (SaaS) and platform as a service (PaaS) revenues were $451 million, up 34% in U.S. dollars and up 38% in constant currency. Cloud infrastructure as a service (IaaS) revenues were $160 million, up 16% in U.S. dollars and up 23% in constant currency. Total On-Premise Software Revenues were $5.8 billion, down 4% in U.S. dollars but up 4% in constant currency. Total Hardware Revenues were $1.1 billion, down 3% in U.S. dollars but up 6% in constant currency. Total Services Revenues were $862 million, up 1% in U.S. dollars and up 10% in constant currency.
Operating Income was $2.7 billion and Operating Margin was 31%. Non-GAAP Operating Income was $3.5 billion and non-GAAP Operating Margin was 41%. Net Income was $1.7 billion while non-GAAP Net Income was $2.3 billion. Earnings Per Share was $0.40, while non-GAAP Earnings Per Share was $0.53. Without the impact of the U.S. dollar strengthening contrast to foreign currencies, Oracle’s stated Q1 GAAP and non-GAAP Earnings Per Share would have been 6 cents higher.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
Metlife Inc (NYSE:MET)’s shares dropped -2.69% to $46.52.
Award-winning morning show The Balancing Act® will feature a “Be the Change” segment on how corporate America is empowering people to build better lives on Friday, September 18 and Friday, September 25 at 7:30 a.m. (ET/PT) on Lifetime®.
“Providing quality, affordable financial tools and know-how for those in need” is the objective behind MetLife Foundation’s on-going efforts in communities across the world. Working in collaboration with the Local Initiatives Support Corporation or LISC, the two have partnered to help struggling men and women pursue their goals, such as finding a better job or improving their financial lives — from building credit to sound habits around savings and budgeting. LISC’s Financial Opportunity Centers, funded in part by MetLife Foundation, help working individuals, especially working mothers, nationwide. Join MetLife Foundation’s April Hawkins, and LISC’s Sueng Kim as they sit down with Jennifer Castañón, a woman who is living proof that corporations and their nonprofit partners are helping those less fortunate. TV Host Julie Moran leads the charge in this engaging “Be the Change” segment. For additional information please go to www.metlife.org.
MetLife, Inc. provides life insurance, annuities, employee benefits, and asset administration products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Operatesite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa.
At the end of Friday’s trade, Keryx Biopharmaceuticals (NASDAQ:KERX)‘s shares dipped -5.39% to $4.39.
Keryx Biopharmaceuticals, Inc, (KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease, declared that corporate presentations would be delivered at the following investor conference.
Ladenburg Thalmann 2015 Healthcare Conference
Presenter: Scott Holmes, Chief Financial Officer.
Presentation Date: Tuesday, September 29, 2015.
Presentation Time: 1:00 p.m. ET.
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
Target Corporation (NYSE:TGT), ended its Friday’s trading session with -1.77% loss, and closed at $76.61.
The board of directors of Target Corporation (TGT) has declared a quarterly dividend of 56 cents per common share. The dividend is payable December 10, 2015 to shareholders of record at the close of business November 18, 2015. The 4th quarter dividend will be the company’s 193rd successive dividend paid since October 1967 when the company became publicly held.
Target Corporation operates as a general merchandise retailer in the United States and Canada. It offers household essentials, counting pharmacy, beauty, personal care, baby care, cleaning, and paper products; music, movies, books, computer software, sporting goods, and toys; electronics, such as video game hardware and software; and apparel for women, men, boys, girls, toddlers, infants, and newborns, in addition to intimate apparel, jewelry, accessories, and shoes.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
